** Shares of vaccine maker Novavax NVAX.O gain 4.6% to $8.80 premarket
** NVAX to sell its Czech Republic manufacturing facility to Novo Nordisk NOVOb.CO for $200 mln, co says
** NVAX expects to reduce annual operating costs by ~$80 mln
** The deal expected to close by Dec. 30
** NOVO up 0.5% at $109.73 premarket
** 3 of 6 brokerages rate NVAX "buy" or higher, 2 "hold" and 1 "sell"; their median PT is $19 - LSEG
** As of last close, NVAX has risen 75.2% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。